Search Results - "Long OS"

Outcomes of an Alpha-DC-1 Dendritic Cell-Based Vaccine Clinical Trial in Patients with Low-Tumor-Burden High-Risk Ovarian Carcinoma.

Authors: Stiff, Patrick J. Czerlanis, Cheryl M. Potkul, Ronald K. et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1285. 22p.

Pre-Specified Safety Analysis of OS Data for Trials in Indolent or Early-Stage Cancers.

Authors: Shan, Minghua¹ (AUTHOR) minghua.shan@bayer.com

Source: Statistics in Biopharmaceutical Research. Apr-Jun2026, Vol. 18 Issue 2, p230-234. 5p.

Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine.

Authors: Bresser, Helena Schmoor, Claudia Grishina, Olga et al.

Source: European Journal of Haematology. Feb2025, Vol. 114 Issue 2, p231-237. 7p.

Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine.

Authors: Güçlü Kantar, Taliha Doğan, Tolga Taş, Semra et al.

Source: Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 11, p1746. 15p.

Survival and Response Outcomes for Gastrointestinal Neuroendocrine Tumor (GEP-NETs) Patients Treated with Lutetium—177-DOTATATE in a Brazilian Reference Center: A Six-Year Follow-Up Experience.

Authors: de Souza, Zenaide Silva Xavier, Camila Bragança Gomes, Luciana Beatriz Mendes et al.

Source: Cancers. Sep2023, Vol. 15 Issue 18, p4506. 11p.

Systematic Review of Monocyte Transcriptomic Profiles as Diagnostic and Prognostic Biomarkers in Colorectal Cancer.

Authors: Podadera-Herreros, Alicia Pilo, Jesús Rego-Calvo, Alejandro et al.

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p4143. 21p.

MGMT Promoter and Enhancer Methylation in Melanoma Brain Metastases and Glioblastoma: Shared and Distinct Features.

Authors: Pühringer, Katharina Fehringer, Benno Zappe, Katja et al.

Source: Cells (2073-4409). Mar2026, Vol. 15 Issue 5, p410. 21p.

Noninvasive Therapeutic Monitoring of Circulating Tumor DNA in BRAF‐Mutant Metastatic Colon Cancer Using Droplet Digital PCR, Next‐Generation Sequencing, and Fragmentomics.

Authors: Lam, Rachel C. T. Hui, Connie W. C. Tse, Irene O. L. et al.

Source: Case Reports in Oncological Medicine. 11/7/2025, Vol. 2025, p1-7. 7p.

Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer.

Authors: Dora, David Weiss, Glen J. Megyesfalvi, Zsolt et al.

Source: Cancers. Oct2023, Vol. 15 Issue 20, p5091. 19p.

Phase II Study of Pegvorhyaluronidase Alfa (PEGPH20) and Pembrolizumab for Patients with Hyaluronan-High, Pretreated Metastatic Pancreatic Ductal Adenocarcinoma: PCRT16-001.

Authors: Chiorean, Elena Gabriela Damle, Sheela R. Zhen, David B. et al.

Source: Cancers. Feb2026, Vol. 18 Issue 3, p507. 17p.

Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: a single-center, retrospective cohort study.

Authors: Funamizu, Naotake Sakamoto, Akimasa Utsunomiya, Takeshi et al.

Source: Scientific Reports. 8/11/2022, Vol. 12 Issue 1, p1-8. 8p.

The SIRT Family: Subcellular Localization and Main Functions.

Authors: Quan, Ping Schatz, Christoph Filippini, Daria Maria et al.

Source: International Journal of Molecular Sciences. Jul2026, Vol. 27 Issue 13, p6042. 22p.

An unusual new species and additional fossils of the penguin-like Plotopteridae from the Paleogene of Washington State, USA.

Authors: Mayr, Gerald Goedert, James L.

Source: Historical Biology. Jun2026, Vol. 38 Issue 6, p2154-2173. 20p.

Allogeneic Hematopoietic Stem Cell Transplantation in Refractory Multiple Myeloma—A Retrospective Multicenter Analysis.

Authors: Richardson, T. Kobbe, G. Fenk, R. et al.

Source: European Journal of Haematology. Mar2025, Vol. 114 Issue 3, p423-428. 6p.

Novel proteomic characterization of multiple myeloma bone marrow interstitial fluid links prognosis to coagulation pathways.

Authors: Cutler, Sam Trottier, Amy M. Liwski, Robert et al.

Source: Clinical Proteomics. 10/21/2025, Vol. 22 Issue 1, p1-14. 14p.

Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial.

Authors: Zhao, Xiao Zhang, Jing Qiu, Lupeng et al.

Source: BMC Medicine. 10/6/2025, Vol. 23 Issue 1, p1-12. 12p.

Research progress of dosiomics in precision radiotherapy.

Authors: Lei, Yifan Bai, Han Yu, Jinhui et al.

Source: Journal of Cancer Research & Therapeutics. Sep2025, Vol. 21 Issue 4, p787-795. 9p.

This result is not displayed to guests.
Login for full access.

Long-Term Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in Real-World Clinical Practice.

Authors: Furuse, Junji Izumi, Namiki Motomura, Kenta et al.

Source: Cancers. Feb2025, Vol. 17 Issue 3, p479. 19p.

Relative Dose Intensity of Daratumumab, Lenalidomide, and Dexamethasone in Multiple Myeloma.

Authors: Suzuki, Kazuhito Gunji, Tadahiro Kawashima, Masaharu et al.

Source: Cancers. Feb2025, Vol. 17 Issue 3, p470. 13p.